The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

December 2022

We’re updating review threshold for high-dollar prepayments

What you need to know

Effective Jan. 1, 2023, high-cost claims greater than $75,000 are now eligible for high-dollar prepayment review by Blue Cross and Blue Care Network. This change only affects the review threshold. It doesn’t affect any other aspect of the current high-dollar prepayment review process.

Since 2017, Blue Cross Blue Shield of Michigan and Blue Care Network have been partnering with Equian, an independent company, to review certain types of high-cost inpatient claims. This review helps us detect and resolve errors before payment to ensure that all claims will be paid right the first time.

As we previously communicated, Blue Cross and BCN intended to review high-cost claims greater than $25,000. But since beginning the review process in May 2017, we’ve only examined claims greater than $100,000. After five years of reviews at this higher amount, Blue Cross and BCN have decided to lower the review threshold.

Effective Jan. 1, 2023, high-cost claims greater than $75,000 are now eligible for high-dollar prepayment review by Blue Cross and BCN.

This change only affects the review threshold. It doesn’t affect any other aspect of the current high-dollar prepayment review process, including claim payments and reconsideration time frames.

For more information:

If you have any questions, contact your provider consultant.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2021 American Medical Association. All rights reserved.